Publications
Export 50 results:
Filters: Keyword is Schizophrenia [Clear All Filters]
, “Liability indicators aggregate many years before transition to illness in offspring descending from kindreds affected by schizophrenia or bipolar disorder.”, Schizophr Res, vol. 175, no. 1-3, pp. 186-192, 2016.
, “Childhood abuse and neglect may induce deficits in cognitive precursors of psychosis in high-risk children.”, J Psychiatry Neurosci, vol. 40, no. 5, pp. 336-43, 2015.
, “Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions.”, Curr Pharm Des, vol. 21, no. 23, pp. 3373-83, 2015.
, “On the validity of within-nuclear-family genetic association analysis in samples of extended families.”, Stat Appl Genet Mol Biol, vol. 14, no. 6, pp. 533-49, 2015.
, “Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder.”, Biol Psychiatry, vol. 76, no. 2, pp. 93-100, 2014.
, “Hippocampus and amygdala volumes in children and young adults at high-risk of schizophrenia: research synthesis.”, Schizophr Res, vol. 156, no. 1, pp. 76-86, 2014.
, “A systematic review on improving cognition in schizophrenia: which is the more commonly used type of training, practice or strategy learning?”, BMC Psychiatry, vol. 14, p. 139, 2014.
, “Abnormal striatal dopamine transmission in schizophrenia.”, Curr Med Chem, vol. 20, no. 3, pp. 397-404, 2013.
, “A protective-compensatory model may reconcile the genetic and the developmental findings in schizophrenia.”, Schizophr Res, vol. 144, no. 1-3, pp. 9-15, 2013.
, “Social cognition in first-degree relatives of people with schizophrenia: a meta-analysis.”, Psychiatry Res, vol. 209, no. 2, pp. 129-35, 2013.
, “Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia.”, Br J Psychiatry, vol. 200, no. 4, pp. 300-7, 2012.
, “[Cognitive-behavioural therapy in early psychosis: an open study in a clinical setting].”, Can J Psychiatry, vol. 56, no. 1, pp. 51-61, 2011.
, “How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.”, Schizophr Bull, vol. 37, no. 4, pp. 811-21, 2011.
, “A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes.”, Am J Psychiatry, vol. 168, no. 5, pp. 472-85, 2011.
, “The study of social cognition with neuroimaging methods as a means to explore future directions of deficit evaluation in schizophrenia?”, Psychiatry Res, vol. 190, no. 1, pp. 23-31, 2011.
, “Familiarity and recollection processes in patients with recent-onset schizophrenia and their unaffected parents.”, Psychiatry Res, vol. 175, no. 1-2, pp. 15-21, 2010.
, “Parietal cortex and episodic memory retrieval in schizophrenia.”, Psychiatry Res, vol. 182, no. 3, pp. 191-9, 2010.
, “Retinal response to light in young nonaffected offspring at high genetic risk of neuropsychiatric brain disorders.”, Biol Psychiatry, vol. 67, no. 3, pp. 270-4, 2010.
, “Insights from the examination of verbal and spatial memory errors in relation to clinical symptoms of patients with recent-onset schizophrenia.”, Cogn Neuropsychiatry, vol. 14, no. 6, pp. 542-58, 2009.
, “A new strategy for linkage analysis under epistasis taking into account genetic heterogeneity.”, Hum Hered, vol. 68, no. 4, pp. 231-42, 2009.
, “Selective pair recognition memory impairment with no response bias in schizophrenia.”, Psychiatry Res, vol. 169, no. 1, pp. 39-42, 2009.
, “Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families.”, Schizophr Bull, vol. 35, no. 5, pp. 919-30, 2009.
, “Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.”, Am J Drug Alcohol Abuse, vol. 34, no. 1, pp. 75-82, 2008.
, “Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes.”, Schizophr Res, vol. 100, no. 1-3, pp. 281-90, 2008.
, “Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.”, J Psychopharmacol, vol. 22, no. 3, pp. 262-9, 2008.
